Your browser doesn't support javascript.
loading
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior.
Schneider, Miriam; Kasanetz, Fernando; Lynch, Diane L; Friemel, Chris M; Lassalle, Olivier; Hurst, Dow P; Steindel, Frauke; Monory, Krisztina; Schäfer, Carola; Miederer, Isabelle; Leweke, F Markus; Schreckenberger, Mathias; Lutz, Beat; Reggio, Patricia H; Manzoni, Olivier J; Spanagel, Rainer.
Affiliation
  • Schneider M; Institute of Psychopharmacology and Research Group Developmental Neuropsychopharmacology, Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany, miriam.schneider@zi-mannheim.de.
  • Kasanetz F; INSERM, Neurocentre Magendie, and University of Bordeaux, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U862, F-33000 Bordeaux, France.
  • Lynch DL; Center for Drug Discovery, Department of Chemistry and Biochemistry, University of North Carolina, Greensboro, North Carolina 27402.
  • Friemel CM; Research Group Developmental Neuropsychopharmacology, Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
  • Lassalle O; INSERM, U901, Marseille 13009, France, Université de la Méditerranée, UMR S901 Aix-Marseille 2, France, INMED, Marseille 13009, France.
  • Hurst DP; Center for Drug Discovery, Department of Chemistry and Biochemistry, University of North Carolina, Greensboro, North Carolina 27402.
  • Steindel F; Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, 55128 Mainz, Germany.
  • Monory K; Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, 55128 Mainz, Germany.
  • Schäfer C; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany, Department of Psychiatry and Psychotherapy, University of Cologne, 50924 Cologne, Germany, and.
  • Miederer I; Department of Nuclear Medicine, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • Leweke FM; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
  • Schreckenberger M; Department of Nuclear Medicine, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • Lutz B; Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, 55128 Mainz, Germany.
  • Reggio PH; Center for Drug Discovery, Department of Chemistry and Biochemistry, University of North Carolina, Greensboro, North Carolina 27402.
  • Manzoni OJ; INSERM, U901, Marseille 13009, France, Université de la Méditerranée, UMR S901 Aix-Marseille 2, France, INMED, Marseille 13009, France.
  • Spanagel R; Institute of Psychopharmacology and.
J Neurosci ; 35(41): 13975-88, 2015 Oct 14.
Article in En | MEDLINE | ID: mdl-26468198
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Behavior, Animal / Adolescent Behavior / Receptor, Cannabinoid, CB1 Type of study: Etiology_studies / Prognostic_studies Limits: Adolescent / Animals / Humans / Male Language: En Journal: J Neurosci Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Behavior, Animal / Adolescent Behavior / Receptor, Cannabinoid, CB1 Type of study: Etiology_studies / Prognostic_studies Limits: Adolescent / Animals / Humans / Male Language: En Journal: J Neurosci Year: 2015 Document type: Article